SureTrader
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

CTIX RSS Feed
Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: BigKahuna, BooDog, noretreat, TOB, sox040713, TheHound
Search This Board:
Last Post: 2/7/2016 3:19:43 PM - Followers: 685 - Board type: Free - Posts Today: 10

Cellceutix Corporation (CTIX) 
 

 

http://cellceutix.com/
 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
 
CIK:  0001355250
 
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.

 

Management:   http://cellceutix.com/team/
The above link is kept updated.
http://www.zoominfo.com/p/Daniel-Jorgensen/1064701588
 

 
Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
 
Product Pipeline:  http://cellceutix.com/pipeline/

 

 
Recent News and Press Releases: 
http://finance.yahoo.com/q/h?s=CTIX+Headlines

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
 
http://cellceutix.com/category/press-release/

A randomized, double-blind study comparing single-dose and short-course brilacidin to daptomycin in the treatment of acute bacterial skin & skin structure infections (ABSSSI)

http://eccmid.meetingexpert.net/ECCMID_546/poster_122533/program.aspx/anchor122533

Synthetic novel host defense protein mimetics for the treatment of Gram-negative bacterial infections

http://eccmid.meetingexpert.net/ECCMID_546/poster_122353/program.aspx

 
SEC Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com/

 
Share Structure:  See SEC filing link above for current share structure
 

Cellceutix IP - Patent Filings:
EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 


http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,796,275.PN.&OS=PN/8,796,275&RS=PN/8,796,275
 

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet


http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations:  info@cellceutix.com

Following is a WEEKLY chart:


 
 

 
 
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTIX
Current Price
Volume:
Bid Ask Day's Range
Wiki
CTIX News: Amended Statement of Ownership (sc 13g/a) 01/27/2016 09:57:11 AM
CTIX News: Small Cap Stocks Are Heating up Again, Small Cap Street is Covering (OTCQB: ELTP),(OTCBB: AHIX), (OTCBB: AXXE), (OTCBB: CTIX) 01/26/2016 07:40:00 AM
CTIX News: Current Report Filing (8-k) 12/21/2015 08:19:27 AM
CTIX News: Statement of Changes in Beneficial Ownership (4) 12/18/2015 12:17:11 PM
CTIX News: Quarterly Report (10-q) 11/09/2015 04:13:18 PM
PostSubject
#138248  Sticky Note 1-26-16 $CTIX ~ Cellceutix Corp. Due Diligence Report TheHound 01/26/16 01:54:21 PM
#137845  Sticky Note Cellceutix Releases Data Used in Receiving FDA Orphan GregChase 01/22/16 12:06:04 PM
#137447  Sticky Note News: Cellceutix Submits Briefing Book for Phase 2 BooDog 01/19/16 08:36:10 AM
#133344  Sticky Note We are looking forward ... to our fiscal noretreat 12/14/15 02:58:59 PM
#132379  Sticky Note CTIX Potential Catalysts and Past Milestones sox040713 12/07/15 11:39:25 AM
#117003  Sticky Note Cellceutix released efficacy data for Kevetrin, its cancer TOB 08/09/15 03:05:24 PM
#139193   Among the several p53 drugs, MD Anderson as BigKahuna 02/07/16 03:19:43 PM
#139192   a recent discovery out of MD Anderson on Waverunner1 02/07/16 02:27:55 PM
#139191   In all articles on K never read anything Amatuer17 02/07/16 12:48:53 PM
#139190   I think this part is exactly right - Waverunner1 02/07/16 11:36:41 AM
#139189   A prophylactic role for kevetrin? Could it prevent xoc 02/07/16 10:36:54 AM
#139188   Flash - had seen this video before - Amatuer17 02/07/16 09:37:54 AM
#139187   Totality of the circumstances. Identifying one factor scottsmith 02/07/16 09:35:44 AM
#139186   You can look at it that way too. frrol 02/07/16 09:12:47 AM
#139185   Only survival is a partnership-they need to sell tombrady12nh 02/07/16 08:59:30 AM
#139184   What's really wrong with Cellceutix? I don't think DesireToLearn 02/07/16 08:38:41 AM
#139183   F1ash THANKS AGAIN !!! great little video too. 1hb 02/06/16 10:55:26 PM
#139182   Glad you added the PS. That seems F1ash 02/06/16 10:02:02 PM
#139181   You're right in that some research says p53 frrol 02/06/16 09:01:53 PM
#139179   Directly or indirectly, if P-53 does in fact Waverunner1 02/06/16 06:42:50 PM
#139177   Kevetrin is not a "checkpoint inhibitor" in any frrol 02/06/16 05:26:34 PM
#139176   one perspective, i imagine... just thought it was a Ringrock 02/06/16 11:11:30 AM
#139175   Awesome hopefully it will take us all out tombrady12nh 02/06/16 11:06:20 AM
#139174   End of Days? TheDane 02/06/16 11:01:31 AM
#139173   https://media.giphy.com/media/26FPF8GFFVZ9izFba/giphy.gif Ringrock 02/06/16 10:51:58 AM
#139172   Thanks tombrady12nh 02/06/16 10:12:55 AM
#139171   I am pretty sure, that rather than being F1ash 02/06/16 10:06:01 AM
#139170   From post 139169 compound. In addition to its p53 tombrady12nh 02/06/16 09:50:47 AM
#139169   great morning read... thanks for the links, solid Ringrock 02/06/16 08:14:55 AM
#139167   Re: F1ash "I wonder if any of the 1hb 02/06/16 01:24:30 AM
#139166   Post-of-the-day warrenthomas4001 02/05/16 11:02:21 PM
#139165   A couple of issues out of the company's etradeedge 02/05/16 09:29:28 PM
#139164   What, cult stock? Oh, wait, you said half TheDane 02/05/16 09:11:48 PM
#139161   "Makes me wonder if I am a smart TheHound 02/05/16 07:40:40 PM
#139160   It's not. The stock is on its way Phteven C 02/05/16 07:17:00 PM
#139159   I wonder if any of the docs here F1ash 02/05/16 06:43:39 PM
#139158   FINRA short sales of CTIX AlanC 02/05/16 06:25:50 PM
#139157   well you know, gotta keep those charts lookin Ringrock 02/05/16 06:13:54 PM
#139156   BK I agree with you and have experienced 58nout 02/05/16 05:52:46 PM
#139155   I agree about what youre saying. 123tom 02/05/16 04:26:03 PM
#139154   Carter, as an ex-president, has the latest and BigKahuna 02/05/16 04:18:16 PM
#139153   "Currently a $0.06 spread on CTIX (about 5%). TheHound 02/05/16 04:07:43 PM
#139152   Nice art work. incubus-now 02/05/16 04:03:44 PM
#139151   This has become officially big news developing with 123tom 02/05/16 03:49:35 PM
#139150   CTIX chart.... 123tom 02/05/16 03:43:20 PM
#139148   could be another paint competition at close. incubus-now 02/05/16 03:20:17 PM
#139147   It will hurt a bit whether we give Phteven C 02/05/16 03:18:16 PM
#139146   To balance out my previous post, and give I Need Help 02/05/16 03:17:36 PM
#139145   "...expect 10Q filing next week." Looking forward to it. Matagordaville 02/05/16 02:54:44 PM
#139144   KarinCA, you continue to earn my respect for Citrati 02/05/16 02:42:52 PM
#139143   The dilution coming up is going to be TimetoRetire 02/05/16 02:34:27 PM
#139142   Yes, the overall market has been lousy. KarinCA 02/05/16 02:21:50 PM
#139141   There you go bashing again KarinCA! cabel 02/05/16 02:20:57 PM
#139140   As a rule, I don't predict prices. KarinCA 02/05/16 02:17:32 PM
#139138   Bear market in biotech and whole market for groton68 02/05/16 01:58:31 PM
#139135   IBB is still going down. Very few KarinCA 02/05/16 01:46:44 PM
PostSubject